Abstract

http://ssrn.com/abstract=715341
 
 

Citations



 


 



The Challenge to Patent Law of Pure Chemical Protein Synthesis


Aaron Xavier Fellmeth


Arizona State University (ASU) - Sandra Day O'Connor College of Law


Nature Biotechology, Vol. 23, No. 5

Abstract:     
This article argues that the emergence of pure chemical protein synthesis as a commercially viable method of drug design and production will create serious problems in the patent system and explains why. Patents on recombinant proteins will block research on and the commercialization of these same proteins produced through chemical synthesis, with accompanying negative effects for medical research. This looming problem illustrates why patents on naturally occurring proteins should not be granted. In the future, chemists must now focus on modifying such natural proteins to avoid the patents.

Keywords: Patent law, biotechnology

Accepted Paper Series


Not Available For Download

Date posted: May 7, 2005  

Suggested Citation

Fellmeth, Aaron Xavier, The Challenge to Patent Law of Pure Chemical Protein Synthesis. Nature Biotechology, Vol. 23, No. 5. Available at SSRN: http://ssrn.com/abstract=715341

Contact Information

Aaron Xavier Fellmeth (Contact Author)
Arizona State University (ASU) - Sandra Day O'Connor College of Law ( email )
Box 877906
Tempe, AZ 85287-7906
United States
Feedback to SSRN


Paper statistics
Abstract Views: 396
Paper comments
No comments have been made on this paper

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo1 in 0.266 seconds